Senior Principal Scientist
Bristol-Myers Squibb Company
Yanshan Dai, PhD, is a Senior Principal Scientist in Nonclinical Disposition and Bioanalysis at Bristol Myers Squibb, Princeton, NJ. He has developed AAV total binding antibody assay and cell-based neutralizing antibody assay to support AAV gene therapy since 2015. He has also developed digital PCR assay and ELISPOT immunogenicity assay to support CAR-T cell therapy programs.